FDA Drug Application (021513) for ENABLEX by APIL

Back to FDA Applications sponsored by APIL

Application Number021513
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 7.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameENABLEX
Active IngredientDARIFENACIN HYDROBROMIDE

Active IngredientCount
List of drugs with Active Ingredient DARIFENACIN HYDROBROMIDE2


Back to FDA Applications sponsored by APIL